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1 Introduction
The growth retarded infant runs an increased
risk of perinatal death and long-term morbidity
[12, 22]. Methods for antenatal identification
of intrauterine growth retardation (IUGR) are
important.
Clinical evaluation of fetal growth is difficult
and often inaccurate. In studies evaluating
routine antenatal care, fewer than 50 per cent
of the growth retarded infants were suspected
[8, 19], and for every correct diagnosis there
were 2.5 false positive diagnoses [8].
.For successful antenatal diagnosis of IUGR, a
highly sensitive and simple screening procedure
is needed. Accordingly it should be possible
to identify a limited risk group which can be
supervised more carefully during pregnancy
with respect to fetal growth.
The association between the symphysis-fundus
(SF) distance and fetal weight has been known
since the 1950's [21]. In 1973, when LEROY et
al. [11] published a standard curve measuring
the SF growth during pregnancy, WESTIN pre-
sented a similar curve in Sweden [26]. The
method has also been evaluated by BELIZÄN [1]
and CALVERT [2]. According to WESTIN, not
only the low but also the static SF curve in-
dicates IUGR [27]. In accordance with
CALVERT [2], we found that when denoting the
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static SF curve as pathological, the number of
false positive cases were substantially increased
[4].
The SF curve has been in routine use at the
majority of the Swedish antenatal care clinics
since the mid-seventies. Practically all pregnant
women visit these clinics regularily.
Lately, repeated ultrasonic measurements of
fetal dimensions have given us new possibilities
to estimate fetal growth. It seems doubtful if
this method can be used for screening purposes
since it requires a specialized staff and
expensive equipment. Furthermore, as in gen-
eral, when a new diagnostic method is in-
troduced, the primary concern has been to show
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that it is useful for the specific diagnosis re-
quested, rather than to show that is adds new
information or is superior to the diagnostic
methods already in common use. When re-
peated ultrasonic measurements of the
biparietal diameter (BPD) were introduced in
Sweden as a method to detect fetal growth
disturbances, it was assumed rather than
demonstrated that this instrument was superior
to the SF curve in predicting growth retarded
infants [16]. Repeated ultrasonic BPD meas-
urements were the first and are probably still
the most commonly used ultrasonic method of
estimating fetal growth [3].
In this report, the diagnostic efficiency of the
• SF curve in predicting IUGR is compared with
that of repeated ultrasonic BPD measurements.
2 Materials and methods
This study was performed in Uppsala County,
Sweden. Since June 1979 a program has been
in use for the follow-up of pregnant women
with risk factors for IUGR [5]. In 1980, 3,022
Scandinavian women from the County
delivered live singleton born infants at the Uni-
versity Hospital, Uppsala. In 377 pregnancies
with risk factors, fetal growth was followed
by repeated measurements of the symphysis-
fundus distance (SF) as well as with repeated
ultrasonic measurements of the biparietal dia-
meter (BPD). Only these patients were included
in the present study. SF measurements were
performed by the midwives at the antenatal
care clinics, according to the directions by
WESTIN [28]. Measurements were performed
every second week from the 20th to the 36th
week and thereafter weekly. A SF curve with
at least one measurement three or more cm
below the mean of the normal curve was con-
sidered as pathological [4].
The ultrasonic BPD measurements (sound
velocity l,540m/sec.) were performed by two
specially trained assistents with four years ex-
perience with the technique. The measurements
were made according to CAMPBELL [3]. The first
measurement was performed between the 16th
and 21st gestational week. The second BPD
measurement, done at least ten weeks after the
first, was performed within the zone of linear
BPD growth (i. e. before the 33rd gestational
week [16]). If the mean weekly increase
was < 2.85 mm, BPD growth was assessed as
pathological [16]. In term pregnancies (gesta-
tional age > 36 completed weeks, n = 358), a
third measurement was performed between
week 37 and term. BPD growth was also as-
sessed as pathological if this measurement was
2 SD or more below the mean of the Swedish
BPD growth curve [17, 18].
Definitions:
Gestational age: In completed weeks according
to the first performed ultrasonic BPD meas-
urement [7].
Moderate growth retardation: Birthweight for
gestational age < — 1 SD and above — 2 SD
from the mean, according to the Swedish
growth curves used [9].
Severe growth retardation: Birthweight for
gestational age < — 2 SD from the mean
according to the Swedish growth curves.
The sensitivity (%) of a method in indicating
IUGR was defined as:
True positive χ 100
True positive + false negative
The specificity (%) was defined as:
True negative χ 100
True negative + false positive
The predicted value of a positive test (%) was
defined as:
True positive χ 100
True positive + false positive
The predicted value of a negative test (%) was
defined as:
True negative χ 100
True negative + false negative
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3 Results
There were ten severely growth retarded infants
delivered by the studied women (n = 377). As
demonstrated in Fig. 1, pathological SF curves
occurred in 40 pregnancies (ten true positive
and 30 false positive). Pathological BPD growth
occurred in 79 pregnancies (seven true positive
and 72 false positive). In 85 cases (23 per cent)
the methods contradicted each other with re-
spect to fetal growth. Both tests were assessed
as pathological in 17 pregnancies. From this
group, seven severely growth retarded infants
were delivered. No severely growth retarded
infant was delivered when both tests were as-
sessed as normal.
\SF
pathological
normal
totals
pathological
?/17
(41%)
3/23
(13%)
1%o
(25%)
normal
°/62
(0-/J
°/275
(0%)
°/337
(0%)
totals
7/79
(9%)
3/298
(1%)
/377
(3%)
Fig. 1. Test results for women delivering severely growth
retarded infants, in relation to the total number of
women with different combinations of test results.
Thirty-nine severely or moderately growth re-
tarded infants were delivered. Fig. 2 shows that
48 per cent (19/40) of women with pathological
SF curves delivered severely or moderately
growth retarded infants. When BPÖ growth
was assessed as pathological, only 22 per cent
(17/79) delivered severely or moderately growth
retarded infants. When both tests were assessed
as pathological, 71 per cent (12/17) delivered
severely or moderately growth retarded infants.
On the other hand, 38 per cent (15/39) of the
severely or moderately growth retarded infants
pathological
normal
totals
pathological
%
(71%)
7/23
(30%)
%
(48%)
normal
%2
(8%)
%5
(5%)
2%7
(6%)
totals
%
(22%)
22/298
(7%)
39/
/377
(10%)
Fig. 2. Test results for women delivering severely or
moderately growth retarded infants, in relation to the
total number of women with different combinations of
test results.
were delivered by mothers with both tests
normal.
The validity of SF measurements in predicting
IUGR was compared with that of BPD meas-
urements. As is demonstrated in Tab. I, the
diagnostic efficiency of the SF curve was higher
than that of repeated BPD measurements.
Tab. I. Validity of repeated SF and BPD measurements
for standardized birthweight ^ — 2 SD and stan-
dardized birthweight ^ — 1 SD.
Standardized birthweight
g - 2 SD (n = 10)
sensitivity %
specificity %
Predictive value of
a positive test %
Predictive value of
a negative test %
Standardized birthweight
^ - 1 SD (n = 61)
sensitivity %
specificity %
predictive value of
a positive test %
predictive value of
a negative test %
SF
100
92
25
100
49
94
48
94
BPD
70
80
9
99
44
82
22
93
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4 Discussion
In clinical practice, when the obstetrician faces
a pathological BPD or SF measurement, he is
usually disposed to rely more on the technically
advanced method. However, we found that the
clinical value of the SF curve was better than
that of ultrasonic BPD measurements in the
diagnosis of IUGR. In accordance to a recently
published Swedish study [23], we found the
number of false positive cases to be unaccept-
ably high when using repeated ultrasonic BPD
measurements to detect IUGR. Furthermore,
the BPD measurements have a disadvantage in
that they will above all detect the symmetrical
, type of IUGR, which probably includes many
healthy genetically small infants [10]. Symmetri-
cal IUGR may also be caused by chronic
maternal malnutrition, intrauterine infections
or chromosomal anomalies [20]. However,
when these conditions are diagnosed in late
pregnancy, the possibilities of practical therapy
are very limited.
The SF curve is used as a measure of uterine
growth. Therefore, SF measurements are prob-
ably low in both symmetric and assymmetric
IUGR, and especially in cases with
oligohydramnion, which is of clinical im-
portance. Like previous investigators, we found
neither method to be ideal in diagnosing IUGR
[1, 2, 14, 16, 24]. The methods contradicted
each other frequently, which may lead the clini-
cian to abandon his first suspicion.
The number of severely growth retarded infants
were low (n = 10). Although all these infants
were delivered by mothers with pathological SF
curves, this should be regarded with scepticism.
Previous studies report that the majority, but
not all, of the growth retarded infants are
delivered by mothers exhibiting pathological SF
curves [1, 2, 24, 27]. In accordance to previous
studies [1, 2], the results obtained indicate that
the number of false positive cases is unaccept-
ably high, when using the SF curve as a diag-
nostic instrument for IUGR. Instead, the SF
curve should mainly be used as a screening
instrument for severe IUGR.
When the SF curve is assessed as pathological,
other methods should be used. However, if re-
peated BPD measurements are the only ultra-
sonic method in routine use, one should con-
sider to do without this method. The rapid
progress in ultrasound technology has given us
new methods of diagnosing IUGR, such as
measurements of the fetal abdominal diameter
or crown-rump length [15, 18], total in-
trauterine volume [6] or amniotic fluid volume
[13]. Although reported as very successful, these
ultrasonic measurements require considerable
skill and have so far neither been proved to be
more effective than the SF method for
antenatal diagnosis of IUGR [25], nor demon-
strated to improve perinatal outcome [14].
Hence, the final step in the diagnosis of IUGR
is not obvious to-day. However, if not only the
SF curve but also late ultrasonic measurements
are assessed as pathological, this will further
confirm the suspicion of IUGR. Therefore, we
recommend late ultrasonic measurements (in-
cluding other fetal dimensions than BPD), in
cases with pathological SF curves.
Summary
The diagnostic efficiency in the prediction of intrauterine
growth retardation (IUGR) of repeated measurements
of the symphysis-fundus (SF) distance and repeated
ultrasonic measurements of the biparietal diameter
(BPD) was investigated in 377 pregnancies, all at risk
for IUGR.
Measurements of the SF distance were found to be more
effective than ultrasonic BPD measurements for
antenatal diagnosis of IUGR. For every correct diagnosis
there were three false positive when using SF meas-
urements and ten when using ultrasonic BPD meas-
urements. When the SF method is used, repeated ultra-
sonic BPD measurements add very little information.
The SF curve is a very simple and inexpensive method
and should be used as a screening instrument for severe
IUGR. When the SF curve is assessed as pathological,
ultrasonic measurements also including other fetal
dimensions than only BPD are recommended as a way
of diagnosing IUGR.
Keywords: Fetal growth retardation, human pregnancy, screening, symphysis-fundus distance, ultrasonographic
measurement.
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Zusammenfassung
Der klinische Wert von Messungen des Symphysen-Ab-
stands und Ultraschallmessungen des biparietalen Durch-
messers für die Diagnose einer intrauterinen Wachstums-
verzögerung
Bei 377 Schwangerschaften, in denen ein Risiko für eine
intrauterine Wachstumsretardierung (IUGR) vorlag,
wurde die diagnostische Effizienz von wiederholten Mes-
sungen des Abstands zwischen Symphyse und Fundus
(SF) und wiederholten Ultraschallmessungen des bipa-
rietalen Durchmessers (BPD) für die Vorhersage einer
IUGR untersucht.
Messungen des SF-Abstands sind für die pränatale Dia-
gnose einer IUGR effektiver als US-Messungen des
BPD. Auf jede korrekte Diagnose ergaben sich drei
falsch-positive Ergebnisse bei Anwendung der SF-Mes-
sungen und zehn bei Anwendung der BPD-Messungen.
Bei Benutzung der SF-Methode ergeben wiederholte US-
Messungen des BPD sehr wenig an zusätzlicher Informa-
tion. Da die Messung des SF-Abstands eine sehr einfache
und kostensparende Methode ist, sollte die SF-Kurve
als Screening für eine IUGR angewendet werden. In
den Fällen, in denen sich die SF-Kurve als pathologisch
erweist, werden US-Messungen, die neben dem BPD
auch andere Parameter umfassen, für die Diagnose einer
IUGR empfohlen.
Schlüsselwörter: Fetale Wachstumsverzögerung, Schwangerschaft beim Menschen, Screening, Symphysen-Fundus-
Abstand, Ultraschallmessungen.
Resume
Interet clinique des mesures de la distance symphyse
pubienne — fond uterin et des mesures echographiques
du diametre biparietal, en vue de diagnostiquer un retard
de croissance intra-uterin
Nous avons etudie le rendement diagnostique, en vue
de predire un retard de croissance intra-uterin
(R. C. L U.), de mesures repetees de la hauteur uterin
(H. U.) et de mesures ultra-sonores repetees du diametre
biparietal (B. I. P.) au cours de 377 grossesses toutes a
risque de R. C. I. U.
Les mesures de la H. U. s'averent plus operantes que les
mesures ultra-sonores du B. I. P., en ce qui concerne le
diagnostic prenatal d'un R. C. I. U. Pour chaque diag-
nostic correct nous avons enregistre trois faux positifs,
en utilisant la methode des mesures de la H. U. et dix
faux positifs, en utilisant la methode des mesures ultra-
sonores du B. I. P. Quand on se sert de la methode de
la H. U., des mesures ultra-sonores repetees donnent
tres peu d'information supplementaire. Comme les me-
sures de la H. U. constituent une methode tres simple
et tres peu coüteuse, la courbe de H. U. doit etre utilisee
comme instrument de depistage de graves R. C. I. U.
Lorsque la courbe de H. U. est estimee pathologique, il
est recommande d'avoir recours a des mesures ultra-
sonores comprenant aussi d'autres dimensions fetales que
le seul B. I. P., en vue de diagnostiquer un eventuel
R. C. L U.
Mots-cles: Depistage, grossesse, hauteur uterine, mesure echographique, retard de croissance foetale.
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